Search earnings tickers

VRTX

2024Q3AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-11-04 · Fiscal end 2024-09-30 · Features as of 2024-11-04

← Earnings history

Street

Consensus EPS4.13

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.5%

IV front—

P/C full—

P/C front—

Features as of2024-11-04

Run-up

Close—

Ret 5d-0.7%

Ret 10d-1.1%

Ret 20d+5.4%

Ret 30d+2.8%

Print

Actual EPS

4.38Beat

Estimated EPS4.13

Actual revenue

2.8B

Surprise %+6.1%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction+3.5%

Implied vs actual

Implied 2.5%Actual 2.2%

Gap reaction+2.2%

Day result+5.7%

Next-day upYes

Realized / IV0.88×

Post tape

Post 5d-2.0%

Post 10d-10.4%

Post volume1.7M

Vol ×10d1.72×

Vol ×20d1.64×

Post range6.0%